E-LIB Suche - Ergebnisse für: Yoo, Changhoon

1

Brightline-2: a Phase IIa/IIb trial of brigimadlin (BI 9078..:

Changhoon Yoo ; Angela Lamarca ; Hye Jin Choi...
doi:10.25402/fon.24988887.v1. , 2024

Link: https://doi.org/10.25402..

2

Downregulation of Lysosome-Associated Membrane Protein-2A C..:

Jeong, Yun-Jeong ; Lee, Kyoung-Hee ; Woo, Jisu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024500/. , 2023

Link: http://www.ncbi.nlm.nih...

3

Incidence and predictors of esophagogastric varices bleedin..:

Massimo Iavarone ; Eleonora Alimenti ; Toshifumi Tada...
https://beta.karger.com/Article/FullText/534127. , 2023

Link: https://doi.org/10.1159/..

4

Phase 2 trial of bintrafusp alfa as second-line therapy for..:

Yoo, Changhoon ; Javle, Milind M ; Verdaguer Mata, Helena...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442127/. , 2023

Link: http://www.ncbi.nlm.nih...

5

Recent advances in systemic therapy for advanced intrahepat..:

Changhoon Yoo ; Jaewon Hyung ; Stephen L. Chan
https://beta.karger.com/Article/FullText/531458. , 2023

Link: https://doi.org/10.1159/..

6

Randomized phase II study of capecitabine plus cisplatin wi..:

Min‐Hee Ryu ; Kyung Hee Lee ; Lin Shen...
https://doi.org/10.1002/cam4.5536. , 2023

Link: https://doi.org/10.1002/..

7

HMGB1, a potential regulator of tumor microenvironment in K..:

Myung-Ju Lee ; Joohee Park ; Seokjoo Choi...
https://www.frontiersin.org/articles/10.3389/fmicb.2023.1202993/full. , 2023

Link: https://doi.org/10.3389/..

8

Downregulation of Lysosome-Associated Membrane Protein-2A C..:

Jeong, Yun-Jeong ; Lee, Kyoung-Hee ; Woo, Jisu...
info:eu-repo/semantics/altIdentifier/doi/10.2147/COPD.S378386. , 2023

Link: https://www.dovepress.co..

9

Pembrolizumab in combination with gemcitabine and cisplatin..:

Kelley, Robin Kate ; Ueno, Makoto ; Yoo, Changhoon...
The KEYNOTE-966 Investigators , Kelley , R K , Ueno , M , Yoo , C , Finn , R S , Furuse , J , Ren , Z , Yau , T , Klümpen , H-J , Chan , S L , Ozaka , M , Verslype , C , Bouattour , M , Park , J O , Barajas , O , Pelzer , U , Valle , J W , Yu , L , Malhotra , U , Siegel , A B , Edeline , J & Vogel , A 2023 , ' Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial ' , The Lancet . https://doi.org/10.1016/S0140-6736(23)00727-4. , 2023

Link: https://research.manches..

10

FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline..:

Eshmuminov, Dilmurodjon ; Aminjonov, Botirjon ; Palm, Russell F...
info:eu-repo/semantics/altIdentifier/pmid/37020094. , 2023

Link: https://hdl.handle.net/1..

11

A whole-genome reference panel of 14,393 individuals for Ea..:

Choi, Jaeyong ; Kim, Sungjae ; Kim, Juhyun...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411914/. , 2023

Link: http://www.ncbi.nlm.nih...

12

HMGB1, a potential regulator of tumor microenvironment in K..:

Lee, Myung-Ju ; Park, Joohee ; Choi, Seokjoo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374257/. , 2023

Link: http://www.ncbi.nlm.nih...

13

ASO Visual Abstract: FOLFIRINOX or Gemcitabine Based Chemot..:

Eshmuminov, Dilmurodjon ; Aminjonov, Botirjon ; Palm, Russell F...
info:eu-repo/semantics/altIdentifier/pmid/37067744. , 2023

Link: https://hdl.handle.net/1..

14

Efficacy and safety of lenvatinib in patients with recurren..:

Kyunghye Bang ; Andrea Casadei‐Gardini ; Changhoon Yoo...
https://doi.org/10.1002/cam4.5123. , 2023

Link: https://doi.org/10.1002/..

15

614 Safety and efficacy of YBL-006, a novel anti-PD-1 antib..:

Bhumsuk Keam ; Chan-Young Ock ; Do-Youn Oh...
https://doaj.org/toc/2051-1426. , 2023

Link: https://doi.org/10.1136/..